Literature DB >> 27022110

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.

Maeve Mullooly1, Ruth M Pfeiffer2, Sarah J Nyante3, Brandy M Heckman-Stoddard2, Marjorie Perloff2, Ismail Jatoi4, Louise A Brinton2, Erin J Aiello Bowles5, Robert N Hoover2, Andrew Glass6, Amy Berrington de Gonzalez2, Mark E Sherman2, Gretchen L Gierach2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27022110      PMCID： PMC4962703          DOI： 10.1200/JCO.2015.64.4492

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  26 in total

1.  A first evaluation of breast radiological density assessment by QUANTRA software as compared to visual classification.

Authors:  Stefano Ciatto; Daniela Bernardi; Massimo Calabrese; Manuela Durando; Maria Adalgisa Gentilini; Giovanna Mariscotti; Francesco Monetti; Enrica Moriconi; Barbara Pesce; Antonella Roselli; Carmen Stevanin; Margherita Tapparelli; Nehmat Houssami
Journal:  Breast       Date:  2012-01-27       Impact factor: 4.380

2.  Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients.

Authors:  Kazuma Kiyotani; Taisei Mushiroda; Chiyo K Imamura; Yusuke Tanigawara; Naoya Hosono; Michiaki Kubo; Mitsunori Sasa; Yusuke Nakamura; Hitoshi Zembutsu
Journal:  Breast Cancer Res Treat       Date:  2011-09-23       Impact factor: 4.872

3.  Adjusting the dose of tamoxifen in patients with early breast cancer and CYP2D6 poor metabolizer phenotype.

Authors:  Eduardo Martinez de Dueñas; Enrique Ochoa Aranda; Isabel Blancas Lopez-Barajas; Teresa Ferrer Magdalena; Fernando Bandrés Moya; Luis Miguel Chicharro García; José A Gómez Capilla; Mercedes Zafra Ceres; Tomás de Haro; Regina Romero Llorens; Carlos Ferrer Albiach; Rafael Ferriols Lisart; Dolores Chover Lara; Angela López Rodríguez; Javier Munárriz Ferrandis; Santiago Olmos Antón
Journal:  Breast       Date:  2014-03-29       Impact factor: 4.380

4.  Qualitative age interactions in breast cancer studies: mind the gap.

Authors:  William F Anderson; Ismail Jatoi; Mark E Sherman
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

Review 5.  Reasons for nonadherence to tamoxifen and aromatase inhibitors for the treatment of breast cancer: a literature review.

Authors:  Suhila Sawesi; Janet S Carpenter; Josette Jones
Journal:  Clin J Oncol Nurs       Date:  2014-06       Impact factor: 1.027

6.  Breast density measurements using ultrasound tomography for patients undergoing tamoxifen treatment.

Authors:  Mark Sak; Neb Duric; Peter Littrup; Cuiping Li; Lisa Bey-Knight; Mark Sherman; Norman Boyd; Gretchen Gierach
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-03-29

Review 7.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

8.  Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients.

Authors:  Kyung Lan Ko; In Suk Shin; Ji Young You; So-Youn Jung; Jungsil Ro; Eun Sook Lee
Journal:  Breast Cancer Res Treat       Date:  2013-12       Impact factor: 4.872

9.  Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.

Authors:  Jack Cuzick; Ivana Sestak; Michael Baum; Aman Buzdar; Anthony Howell; Mitch Dowsett; John F Forbes
Journal:  Lancet Oncol       Date:  2010-11-17       Impact factor: 41.316

10.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Authors:  C Davies; J Godwin; R Gray; M Clarke; D Cutter; S Darby; P McGale; H C Pan; C Taylor; Y C Wang; M Dowsett; J Ingle; R Peto
Journal:  Lancet       Date:  2011-07-28       Impact factor: 79.321
View more
  13 in total

Review 1.  A review of the influence of mammographic density on breast cancer clinical and pathological phenotype.

Authors:  Michael S Shawky; Cecilia W Huo; Kara Britt; Erik W Thompson; Michael A Henderson; Andrew Redfern
Journal:  Breast Cancer Res Treat       Date:  2019-06-08       Impact factor: 4.872

2.  Ultrasound tomography imaging with waveform sound speed: Parenchymal changes in women undergoing tamoxifen therapy.

Authors:  Mark Sak; Neb Duric; Peter Littrup; Mark Sherman; Gretchen Gierach
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-03

Review 3.  Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.

Authors:  Emma C Atakpa; Mangesh A Thorat; Jack Cuzick; Adam R Brentnall
Journal:  Cochrane Database Syst Rev       Date:  2021-10-26

4.  Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer.

Authors:  Mustapha Abubakar; Maeve Mullooly; Sarah Nyante; Ruth M Pfeiffer; Erin J Aiello Bowles; Renata Cora; Clara Bodelon; Eboneé Butler; Donna Butcher; Lawrence Sternberg; Melissa A Troester; Sheila Weinmann; Mark Sherman; Andrew G Glass; Amy Berrington de Gonzalez; Gretchen L Gierach
Journal:  JNCI Cancer Spectr       Date:  2022-05-02

5.  A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.

Authors:  Cynthia A Thomson; H H Sherry Chow; Betsy C Wertheim; Denise J Roe; Alison Stopeck; Gertraud Maskarinec; Maria Altbach; Pavani Chalasani; Chuan Huang; Meghan B Strom; Jean-Philippe Galons; Patricia A Thompson
Journal:  Breast Cancer Res Treat       Date:  2017-05-30       Impact factor: 4.872

6.  Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis.

Authors:  Cecilia W Huo; Mark Waltham; Christine Khoo; Stephen B Fox; Prue Hill; Shou Chen; Grace L Chew; John T Price; Chau H Nguyen; Elizabeth D Williams; Michael Henderson; Erik W Thompson; Kara L Britt
Journal:  Breast Cancer Res       Date:  2016-10-25       Impact factor: 6.466

7.  The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study.

Authors:  Julia A Knight; Kristina M Blackmore; Jing Fan; Kathleen E Malone; Esther M John; Charles F Lynch; Celine M Vachon; Leslie Bernstein; Jennifer D Brooks; Anne S Reiner; Xiaolin Liang; Meghan Woods; Jonine L Bernstein
Journal:  Breast Cancer Res       Date:  2018-03-22       Impact factor: 6.466

8.  Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer.

Authors:  Louise Eriksson; Wei He; Mikael Eriksson; Keith Humphreys; Jonas Bergh; Per Hall; Kamila Czene
Journal:  JNCI Cancer Spectr       Date:  2019-01-29

9.  Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients.

Authors:  Maeve Mullooly; Sarah J Nyante; Ruth M Pfeiffer; Renata Cora; Donna Butcher; Lawrence Sternberg; Erin J Aiello Bowles; Shaoqi Fan; Jonine D Figueroa; Sheila Weinmann; Robert N Hoover; Louise A Brinton; Amy Berrington de Gonzalez; Andrew Glass; Mark E Sherman; Gretchen L Gierach
Journal:  J Clin Med       Date:  2019-11-04       Impact factor: 4.241

10.  Mammographic density changes in surgical weight loss-an indication for personalized screening.

Authors:  Natalia Partain; Ali Mokdad; Nancy Puzziferri; Jessica Porembka; Stephen Seiler; Alana Christie; Deborah Farr; Aeisha Rivers; A Marilyn Leitch; Rachel Wooldridge; James Huth; Roshni Rao
Journal:  BMC Med Imaging       Date:  2018-05-09       Impact factor: 1.930
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.